ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

In Vivo Study Coordinator at Manifold Bio - ApplyBlast

In Vivo Study Coordinator

Manifold Bio

1 month ago

Boston, Massachusetts, United States

Onsite

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

Manifold Bio is seeking an experienced In Vivo Study Coordinator to manage the end-to-end planning, coordination, and execution of preclinical in vivo pharmacology programs. This senior, hands-on role serves as the single point of accountability for study lifecycle management across multiple parallel programs, from initial design through execution and delivery. The position requires deep expertise in in vivo techniques, strong cross-functional coordination, and the ability to operate independently in a fast-moving biotech environment.

Responsibilities

Oversee and execute preclinical in vivo pharmacology studies
Manage tissue analysis and sample storage from vivarium facilities
Perform test article dosing and rodent perfusion procedures

Skills

Qualifications

Bachelor's degree in Biology, Pharmacology, Biomedical Science, or related fieldMaster's degree in Biology, Pharmacology, Biomedical Science, or related field

About Manifold Bio

manifold.bio

Headquarters

Boston, Massachusetts, United States

Company Size

11-50 employees

View Profile

Manifold Bio is a biotech company that designs tissue-targeted medicines directly in vivo. They built a high-throughput in vivo (HTV) discovery engine that combines massively multiplexed in‑animal screening with AI‑powered design to discover and optimize targeted biologics. The platform enables engineering of tissue- and cell-type‑specific delivery modalities (for example, next‑generation brain shuttles) and supports strategic partnerships with pharma. Their approach aims to accelerate discovery and increase translational success for targeted biologic therapeutics.